EN | 中文

Kunshan RiboQuark Pharmaceutical Science and Technology Co., Ltd (RiboQuark) is a Joint Venture between Quark Pharmaceuticals, Inc. (Quark) and Suzhou Ribo Life Science Co. Ltd. (Ribo) located in Kunshan RNAi & Biomed Park, the center for RNA interference (RNAi) research and development. RiboQuark engages in the discovery and development of novel RNAi based therapeutics with the most robust pipeline of RNAi products in the world and has a fully integrated drug development platform that spans therapeutic target identification to clinical drug development based on proprietary RNAi technology platform.